Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: A randomised study

Lancet

Volumn 360, Issue 9336, 2002, Pages 825-829

  Bonnefoy, Eric ^a   Lapostolle, Frédéric ^b   Leizorovicz, Alain ^c   Steg, Gabriel ^d   McFadden, Eugène P ^a   Dubien, Pierre Yves ^e   Cattan, Simon ^f   Boullenger, Eric ^g   Machecourt, Jacques ^h   Lacroute, Jean Michel ⁱ   Cassagnes, Jean ^j   Dissait, François ^k   Touboul, Paul ^a  

^a LOUIS PRADEL HOSPITAL   (France)

^b SAMU 93   (France)

^c Laennec Rockefeller University   (France)

^d BICHAT HOSPITAL   (France)

^e SAMU 69   (France)

^f CHI Le Raincy   (France)

^g CH de Purpan   (France)

^h GRENOBLE UNIVERSITY HOSPITAL   (France)

ⁱ SAMU 38   (France)

^j UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^k SAMU 63   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; LISINOPRIL; PYRIDINE DERIVATIVE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DEATH; EMERGENCY SURGERY; FEMALE; FIBRINOLYSIS; HEART REINFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ST SEGMENT ELEVATION; STROKE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0037077860     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)09963-4     Document Type: Article

References (28)

1. The GUSTO angiographic investigators . The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function and survival after acute myocardial infarction. N Engl J Med. 329:1993;1615-1622.
2. Gibbons R.J., Holmes D.R., Reeder G.S., Bailey K.R., Hopfenspirger M.R., Gersh B.J. Immediate angioplasty compared with the administration of a fibrinolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med. 328:1993;685-691.
3. Grines C.L., Browne K.F., Marco J., et al. A comparison of immediate angioplasty with fibrinolytic therapy for acute myocardial infarction. N Engl J Med. 328:1993;673-679.
4. Zijlstra F., de Boer M.J., Hoorntje J.C.A., Reiffers S., Reiber J.H.C., Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 328:1993;680-684.
5. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators . A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med. 336:1997;1621-1628.
6. Zahn R., Schiele R., Schneider S., et al. Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction Registry and the Myocardial Infarction Registry. J Am Coll Cardiol. 37:2001;1827-1835.
7. Weaver W.D., Simes R.J., Betriu A., et al. Comparison of primary coronary angioplasty and intravenous fibrinolytic therapy for acute myocardial infarction: a quantitative review. J Am Coll Cardiol. 278:1997;2093-2098.
8. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group . Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 343:1994;311-322.
9. Cannon C.P., Gibson C.M., Lambrew C.T., et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA. 283:2000;2941-2947.
10. The European Myocardial Infarction Project Group . Prehospital fibrinolytic therapy in patients with suspected acute myocardial infarction. N Engl J Med. 329:1993;383-389.
11. Rawles J. Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT). J Am Coll Cardiol. 23:1994;1-5.
12. Weaver W.D., Cerqueira M., Hallstrom A.P., et al. Prehospital-initiated vs hospital-initiated fibrinolytic therapy: the Myocardial Infarction Triage and Intervention Trial. JAMA. 270:1993;1211-1216.
13. Ellis S.G., da Silva E.R., Heyndrickx G., et al. Randomised comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. Circulation. 90:1994;2280-2284.
14. Juliard J.M., Himbert D., Cristofini P., et al. A matched comparison of the combination of prehospital thrombolysis and standby rescue angioplasty with primary angioplasty. Am J Cardiol. 83:1999;305-310.
15. Cannon C.P., Gibson C.M., McCabe C.H., et al. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Circulation. 98:1998;2805-2814.
16. den Heijer P., Vermeer F., Ambrosioni E., et al. Evaluation of a weight-adjusted single-bolus plasminogen activator in patients with myocardial infarction: a double-blind, randomised angiographic trial of lanoteplase versus alteplase. Circulation. 98:1998;2117-2125.
17. Bode C., Smalling R.W., Berg G., et al. Randomised comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. Circulation. 94:1996;891-898.
18. Bar F., Vainer J., Stevenhagen J., et al. Ten-year experience with early angioplasty in 759 patients with acute myocardial infarction. J Am Coll Cardiol. 36:2000;51-58.
19. Boersma E., Maas A.C., Deckers J.W., Simoons M.L. Early fibrinolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet. 348:1996;771-775.
20. Carli P. Prehospital care in France, current status and international controversies. Acta Anaesthesiol Scand Suppl. 110:1997;69-70.
21. Every N.R., Parsons L.S., Hlatky M., Martin J.S., Weaver W.D. A comparison of fibrinolytic therapy with primary coronary angioplasty for acute myocardial infarction. N Engl J Med. 335:1996;1253-1260.
22. Magid D.J., Calonge B.N., Rumsfeld J.S., et al. Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs fibrinolytic therapy. JAMA. 284:2000;3131-3138.
23. The DANAMI-2 study; http://www.theheart.org/index.cfm. (accessed March 20, 2002).
24. Ryan T.J., Antman E.M., Brooks N.H., et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol. 34:1999;890-911.
25. Brass L.M., Lichtman J.H., Wang Y., Gurwitz J.H., Radford M.J., Krumholz H.M. Intracranial hemorrhage associated with fibrinolytic therapy for elderly patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. Stroke. 31:2000;1802-1811.
26. Montalescot G., Barragan P., Wittenberg O., et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med. 344:2001;1895-1903.
27. The Assessment of the Safety and Efficacy of a New Fibrinolytic Regimen (ASSENT)-3 Investigators . Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet. 358:2001;605-613.
28. Assessment of the Safety and Efficacy of a New Fibrinolytic Investigators . Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet. 354:1999;716-722.